AB-FUBINACA: Difference between revisions
>Storm Reworded confusing sentence that seemed to imply cannabis contains full CB agonists |
>Kenan m Reverted edits by Storm (talk) to last revision by Aleksandar8239 |
||
Line 11: | Line 11: | ||
==Pharmacology== | ==Pharmacology== | ||
Although this substance has not been formally studied, from analysis of the structure, it is presumed that AB-FUBINACA has a similar binding profile to that of other [[cannabinoids]] and matches many of the in vivo properties of [[Δ9-THC]]. As with the compounds within [[cannabis]], AB-FUBINACA exhibits its range of effects via [[agonism]] of both the [[Cannabinoid#Cannabinoid_receptor_type_1|CB1]] and [[Cannabinoid#Cannabinoid_receptor_type_2|CB2]] [[cannabinoid]] [[receptors]], with some selectivity for CB2. However, the role of these interactions and how they result in the cannabinoid high experience continues to remain elusive. | Although this substance has not been formally studied, from analysis of the structure, it is presumed that AB-FUBINACA has a similar binding profile to that of other [[cannabinoids]] and matches many of the in vivo properties of [[Δ9-THC]]. As with the compounds within [[cannabis]], AB-FUBINACA exhibits its range of effects via full [[agonism]] of both the [[Cannabinoid#Cannabinoid_receptor_type_1|CB1]] and [[Cannabinoid#Cannabinoid_receptor_type_2|CB2]] [[cannabinoid]] [[receptors]], with some selectivity for CB2. However, the role of these interactions and how they result in the cannabinoid high experience continues to remain elusive. | ||
==Subjective effects== | ==Subjective effects== |